{"name":"Stanley H. Appel, MD","slug":"stanley-h-appel-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOdkh6RlhOczJjbGIwRVBBTkhwUk9YME4taWZQU1NHbXBMNXFlY09qZlVoVzZRY3dDb2JRZU1hdjJEQk1BSVo5ODZqS01uRTlDYzRJbnY2bXQ1SkU0RzhJczFyZDFGRF81aWNseVBWOEl6NFhDbkQ2WktwazF2aGdHWUhOQzRoelN1MnFHZTFGSnc3QU1YczRLSjFFM21MdjJF?oc=5","date":"2024-04-24","type":"pipeline","source":"Clinical Leader","summary":"Validating A Better ALS Biomarker With Coya's Fred Grossman - Clinical Leader","headline":"Validating A Better ALS Biomarker With Coya's Fred Grossman","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBVM3hDNUpSRGlIYXczVXBiUjJtMEpSOV9CVXdhZlA5ZTlCazFvZl9mN2tNcnB3bDV5U1JOUEFJazZDSC1RWVBUNmdET1QyQ3pyRlBRNEg1UEpkQTBhRzJjRHhSMG40OGJkbmc?oc=5","date":"2023-12-09","type":"regulatory","source":"Neurology® Journals","summary":"Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis - Neurology® Journals","headline":"Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons Wi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxONXNsNlNHaFNLdUV5SHJ5RWF1NlhVMFRFVWVPbFVQZVJ1LTBDcTlINUxIMkcyN0c0Zk9DaXZNb1J0SXBSQTM5UGQ1NG53WEZXWjloMU42TnJ0ZF9JSXBxWXpWT2EzRV9nVVFhRXFILXZScTk5SkpuRFVZVmFscVFYdE1jLTVBRnQxU04zTE9aVjhrVDhGNUJISEVqLVpCVG0ycXdJWnRCcEg1RnVaSEl3?oc=5","date":"2022-11-03","type":"trial","source":"neurologylive.com","summary":"Tegoprubart Demonstrates Safety, Target Engagement of ALS Markers in Phase 2 Study - neurologylive.com","headline":"Tegoprubart Demonstrates Safety, Target Engagement of ALS Markers in Phase 2 Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNODJkbzJFeXhLN1NPX2toT0FPbXl5OE5rNTc4X3dJZHVlX1M4TVhURXE0aFB4b3BmVElhNkxNTzNQTEIxWDZiZ3h1NkJTY1Ewd21QWmc5RHFUXzROQXBTWUtaT0hpVE91aWNxNkJWTkMxNUU3ZnNtRzFRM3VpRHFhZTdieU1hME54Vmo0WUQydk9mVk9YdjFyN29R?oc=5","date":"2022-06-02","type":"trial","source":"ALS News Today","summary":"Eledon’s Antibody, Tegoprubart, Shows Promise in ALS Phase 2 Trial - ALS News Today","headline":"Eledon’s Antibody, Tegoprubart, Shows Promise in ALS Phase 2 Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxQMVZ1NDhRNmstTFFuWmFmb2tYUGVxNGY1bU9BMEMzZlpsOEpxUy1YSkh3ZmFZc0V0V2tGMWVyVTlZYUpBUDBKbUwzbnVfZFhOQ195WlRzeHNHdXczTHh2TzhkbnRBeE1YRGJmcHUtVjlkOExLdFRLVkdEVTNRMGdUV0hGc1dhU01DbFZ5Nkk1ajZaM0hPcmhibUFBckRjbUpCdnkwNlMxZVZzcnRKaE1vZzU0ekhCV1JDY3dnWHlObFMtR2FmQUVYQnR6eGEyOGhMUXB3c2QydHNzd0VPallhNVdFSWZHZGpiUHlQYlZlZVZoUHljLWRSekxDU28zU3hEZTgya2gxSld3T1N1c1l4OWp2NlU3WFNjX2g4cmxIbUE1QTYyMkpUX0NZYw?oc=5","date":"2022-05-24","type":"pipeline","source":"PR Newswire","summary":"Stanley H. Appel, MD, World-Renowned ALS Researcher and Clinician, to Receive MDA Tribute Award Honoring 40 Years of Critical Contributions in Medicine - PR Newswire","headline":"Stanley H. Appel, MD, World-Renowned ALS Researcher and Clinician, to Receive MDA Tribute Award Honoring 40 Years of Cri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNV0JRLXBvdFltN2ljb2kzR3lfS01MVFh2Q0d6c3VEd0VjcUdMZHlrUVNXcFN3S2RFakJFOVJyUU91cU9YS2FUT3pmYTJ0SjRJZ2kyanFwMW9YVVo0OXZaV2NsSC1nemJPTVR2ZDJDUWJTeHdkQmxNTmZtcHNRSjVTTnpIMHdJdGRqZGtqLTlTVDNmTVZHWTJTZFNPMUlfc1cwVFE?oc=5","date":"2021-05-19","type":"pipeline","source":"University of Nebraska Medical Center","summary":"Immune transformation shows promise for Parkinson’s disease - University of Nebraska Medical Center","headline":"Immune transformation shows promise for Parkinson’s disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPSWdhcG55LW13NWJOcDFCbjRHZERWcmZMUzZReUxvQzl0VDBOeVJ2cXZHSGVnUHJEeUhrOFdmQzBnSms3dWo2VDNfQUwzZ0N4Y2ZFTk13TF9OWGxvams1c0pZU0l0MVNoX0F3djlpMWpSS1hBZ2FNSHIyd3BjRUx1TDlSa2o3SHhfcHdaVnltbWw2Zw?oc=5","date":"2017-04-26","type":"pipeline","source":"Medical Dialogues","summary":"C-Reactive Protein: A Prognostic Biomarker for ALS? - Medical Dialogues","headline":"C-Reactive Protein: A Prognostic Biomarker for ALS?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPQnJWc0s1Y193VnNQLXV0bW1iczRvWFZBNlFtR3dhei1oa2ZvRkFoNFhldk9aSXZvTEhxS01qNERHWW40RjRvcG5DaGpXR1JyZ0xnQld6TFFFSF9Wdi0tNHh0Znp5ZlgxOURPNkZYUEh6MDkyMDZ0b3hXaHpHQ243T1lrb2xXRXBrYWMzTGZWZ2R0NXhucllXekUxZ3JSM3JFQXFGVlJfS1JlZVVB?oc=5","date":"2017-03-24","type":"pipeline","source":"University of Nebraska Medical Center","summary":"UNMC scientists achieve research milestone with Parkinson’s disease - University of Nebraska Medical Center","headline":"UNMC scientists achieve research milestone with Parkinson’s disease","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}